Treatment Information

Back

Colon Cancer treatment details. Chemotherapy, Biologic therapy.

University of Ulsan College of Medicine, Seoul, Korea.

Survival: monthsCountry:Korea
Toxiciy Grade:5City/State/Province:Seoul
Treatments:Chemotherapy, Biologic therapyHospital:University of Ulsan College of Medicine
Drugs:Journal:Link
Date:Feb 2014

Description:

Patients:
This phase 2 study involved 49 metastatic colorectal cancer patients who were not previously treated. The median patient age was 57 years and 30 were male.

Treatment:
Patients were treated with the chemotherapy agents oxaliplatin and capecitabine, as well as the biologic therapy agent bevacizumab.

Toxicities:
There was one treatment-related death due to heart attack. Grade 4 bowel perforation and grade 3 neutropenia, diarrhea, and nerve toxicity were also reported.

Results:
The median overall survival was 20 months.

Support:
Study medication was provided by Roche Korea Co.

Correspondence: Dr. Tae Won Kim; email: [email protected]



Back